Iannone, Luigi Francesco
Geppetti, Pierangelo
Chiarugi, Alberto
De Cesaris, Francesco http://orcid.org/0000-0003-0326-4485
Article History
Received: 19 May 2021
Accepted: 3 June 2021
First Online: 12 June 2021
Declarations
:
: P.G: received personal fees from Allergan, Eli Lilly, Novartis, Amgen, TEVA; Grants from Amgen, TEVA, Eli Lilly, Allergan, Chiesi; Scientific Advisory Board, Endosome Therapeutics; Founding scientist of FloNext srl, Spinoff of the University of Florence. F.D.C received personal fees from TEVA, Eli Lilly, Novartis. Other authors have no conflicting interests.
: This article does not contain any studies with human or animal subjects performed by the any of the authors.
: Informed consent was obtained from the patient to utilize her medical records for the purpose of this report. All information has been appropriately anonymized.
Free to read: This content has been made available to all.